AI in Pharma
December 4-5, 2018
Investment and the application of AI in the pharmaceutical industry is rapidly gaining momentum. We bring together CEOs, CIOs, CTOs and Global AI, IT and Informatics Experts from leading pharmaceutical and technology companies to give strategic and visionary talks based on use cases throughout the drug development pipeline.
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The Potential for Advanced Analytics in the Pharmaceutical Industry
Michael Ringel, PhD, Senior Partner and Managing Director, Boston Consulting Group (BCG)
Why Is the Pharmaceutical Industry Finding AI so Difficult?
Peter Henstock, AI & Machine Learning Lead, Pfizer
Implementing Digital and AI Strategies across Organizations within Sanofi
Natalija Jovanovic, Head Digital Catalyst, Sanofi
Integrating AI Workflows in Drug Discovery
John Baldoni, Senior Vice President, In silico Drug Discovery, GlaxoSmithKline
The Big Data Revolution: Can AI Shape Drug Discovery?
Litao Zhang, PhD, Vice President, Leads Discovery & Optimization, Disease Sciences & Biologics, BMS
INTERACTIVE PANEL DISCUSSION: The Use of AI to Disrupt Drug Discovery: How to Reduce Time and Costs and Increase Throughput
Moderator: Alex Zhavoronkov, Founder, Insilico Medicine
Panelists:Mark Davies, Vice President Biomedical Informatics, Benevolent AI
Eric Neumann, CEO & Founder, Aidaka
Ed Addison, CEO, Cloud Pharmaceuticals
Session Chairperson: Dany De Grave, Senior Director, Innovation Programs and External Networks, Sanofi
Data Store: Making All Data Machine Learnable at NIBR
John R. Walker, Head of Core Data and Analytics, NIBR Informatics, Novartis
Defining the Strategy and Application of AI in Clinical Trials and Real-World Evidence
Carolyn Cho, Director, Immunology Therapeutic Area Pharmacometrics Lead, Merck
INTERACTIVE PANEL DISCUSSION: Can AI & ML Make Clinical Trials Faster, More Effective and Patient Centric?
Moderator: Craig Lipset, Head of Clinical Innovation, Pfizer
Panelists: Ted Slater, Global Head, Scientific AI & Analytics, Cray
Balazs Flink, MD, Clinical Trial Analytics Lead, R&D Business Insights and Analytics, Bristol-Myers Squibb
Sara Holoubek, CEO, Luminary Labs
Exploring New Ways of Working in Regulatory: Sanofi’s Proof of Concept Pilot
Dany De Grave, Senior Director, Innovation Programs and External Networks, Sanofi